- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1365EUR$1,500USD£1,170GBP
- Report
- December 2021
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2503EUR$2,750USD£2,146GBP
Septicemia Test is a type of infectious disease testing used to detect the presence of sepsis, a life-threatening condition caused by the body's response to an infection. It is typically used to diagnose sepsis in patients with a suspected infection, and is often used in combination with other tests to confirm a diagnosis. The test typically involves a blood sample, which is analyzed for the presence of bacteria, fungi, or other microorganisms. The results of the test can help determine the severity of the infection and the best course of treatment.
The Septicemia Test market is a growing segment of the infectious disease testing industry, as sepsis is a major cause of death worldwide. The market is expected to benefit from the increasing prevalence of sepsis, as well as the development of new technologies and treatments.
Some companies in the Septicemia Test market include Abbott Laboratories, Becton Dickinson, Cepheid, DiaSorin, and Roche Diagnostics. Show Less Read more